MRS-1706: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
Tag: Reverted
Line 57: Line 57:
{{antineoplastic-drug-stub}}
{{antineoplastic-drug-stub}}
{{dictionary-stub1}}
{{dictionary-stub1}}
{{No image}}

Revision as of 22:10, 10 February 2025

Chemical Compound
Identifiers
CAS Number
PubChem CID
ChemSpider ID
UNII
ChEBI
ChEMBL
Properties
Chemical Formula
Molar Mass
Appearance
Density
Melting Point
Boiling Point
Hazards
GHS Pictograms [[File:|50px]]
GHS Signal Word
GHS Hazard Statements
NFPA 704 [[File:|50px]]
References

MRS-1706 is a selective inverse agonist for the adenosine A2B receptor.<ref>Li Q, Ye K, Blad CC, den Dulk H, Brouwer J, Ijzerman AP, Beukers MW. ZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. Journal of Pharmacology and Experimental Therapeutics. 2007 Feb;320(2):637-45. </ref> It inhibits release of interleukins and has an antiinflammatory effect.<ref>Vazquez JF, Clement HW, Sommer O, Schulz E, van Calker D. Local stimulation of the adenosine A2B receptors induces an increased release of IL-6 in mouse striatum: an in vivo microdialysis study. Journal of Neurochemistry. 2008 May;105(3):904-9. </ref><ref>Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Dikov MM, Blackburn MR, Biaggioni I, Feoktistov I. Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. Journal of Immunology. 2008 Jun 1;180(11):7212-20. </ref>

References

<references group="" responsive="1"></references>




This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!